[1] Identification of women at unsuspected risk of primary infection with herpes simplex virus type 2 during pregnancy

[2] A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

[3] Low risk of herpes simplex virus infections in neonates exposed to the virus at the time of vaginal delivery to mothers with recurrent genital herpes simplex virus infections

[4] Cesarean delivery for women presenting with genital herpes lesions. Efficacy, risks, and costs

[5] Reducing the morbidity of lower respiratory tract infections caused by respiratory syncytial virus: still no answer